Katerina Akassoglou Awarded BrightFocus Foundation’s Alzheimer’s Disease Research Grant
CLARKSBURG, Md. (May 13, 2025)—Private research nonprofit BrightFocus Foundation today announced nearly $13 million in grants to support early investigative research into Alzheimer’s disease, macular degeneration, and glaucoma. This includes $7.3 million to its Alzheimer’s Disease Research program, $3.8 million to its Macular Degeneration Research program, and $1.8 million to its National Glaucoma Research program.
Guided by scientific advisory committees of world-renowned researchers in the field, BrightFocus invests in highly innovative, experimental research and creative ideas with the most promise to foster a better understanding of disease onset, improve early detection and diagnosis, develop new treatments, and—ultimately—lead to cures. This year’s grants were awarded to scientists in 10 countries.
“This year’s grant awards represent some of the boldest, most cutting-edge ideas in vision and brain health research,” said BrightFocus President and CEO Stacy Pagos Haller. “With recent major cuts to federal research funding, private foundations like BrightFocus are more essential than ever—stepping up to keep promising research alive, nurture early-career scientists, and accelerate breakthroughs.”
